Katherine M Kocan Selected Research

Anaplasmosis

2/2016	Genomic insights into the Ixodes scapularis tick vector of Lyme disease.
2/2010	The natural history of Anaplasma marginale.
4/2009	Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
2/2008	Expression of perilipin in human promyelocytic cells in response to Anaplasma phagocytophilum infection results in modified lipid metabolism.
10/2006	Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
6/2005	Genetic diversity of anaplasma species major surface proteins and implications for anaplasmosis serodiagnosis and vaccine development.
1/2005	Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle.
6/2004	Anaplasma infection in free-ranging Iberian red deer in the region of Castilla-La Mancha, Spain.
10/2003	Antigens and alternatives for control of Anaplasma marginale infection in cattle.
10/2002	Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine M Kocan Research Topics

Disease

31	Infections 12/2021 - 05/2002
18	Tick Infestations 12/2021 - 03/2003
11	Anaplasmosis 02/2016 - 07/2002
2	Lyme Disease (Disease, Lyme) 02/2016 - 05/2005
2	Bacterial Infections (Bacterial Infection) 01/2015 - 01/2013
2	Persistent Infection 02/2010 - 06/2005
1	red meat allergy 12/2021
1	Hypersensitivity (Allergy) 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 02/2016
1	Necrosis 01/2013
1	Tick Bites 05/2011
1	Anaphylaxis (Anaphylactic Shock) 05/2011
1	Brucellosis (Malta Fever) 05/2009
1	Bovine Tuberculosis 05/2009
1	Tick-Borne Diseases (Tick-Borne Disease) 12/2008
1	Tuberculosis (Tuberculoses) 01/2007
1	Inflammation (Inflammations) 03/2006

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 02/2010 - 03/2003
14	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2003
9	AntigensIBA 07/2009 - 10/2002
6	Membrane Proteins (Integral Membrane Proteins)IBA 10/2006 - 12/2002
4	Recombinant ProteinsIBA 03/2011 - 02/2003
3	Messenger RNA (mRNA)IBA 01/2013 - 09/2007
3	Arthropod ProteinsIBA 02/2010 - 06/2005
3	Inactivated VaccinesIBA 02/2010 - 10/2002
2	ProteomeIBA 01/2015 - 01/2015
2	AntibodiesIBA 05/2011 - 02/2003
2	AcaricidesIBA 06/2007 - 08/2003
2	Biological ProductsIBA 10/2006 - 06/2004
2	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 01/2005
2	Oxytetracycline (Terramycin)FDA Link 01/2006 - 01/2005
2	nucleotidaseIBA 11/2005 - 08/2005
2	Amino Acids FDA Link 05/2005 - 03/2004
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2005 - 07/2002
2	Pharmaceutical PreparationsIBA 01/2005 - 07/2002
2	Merozoite Surface Protein 1 (MSA1)IBA 03/2004 - 02/2003
1	Polysaccharides (Glycans)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Cytochromes c (Cytochrome c)IBA 01/2015
1	PorinsIBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	InterferonsIBA 01/2013
1	Interleukin-12 (IL 12)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	CytokinesIBA 01/2013
1	NF-kappa B (NF-kB)IBA 01/2013
1	thrombospondin 4IBA 08/2012
1	ConnexinsIBA 08/2012
1	Interleukin-1 Receptor Accessory ProteinIBA 08/2012
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 08/2012
1	Immunoglobulin E (IgE)IBA 05/2011
1	OligosaccharidesIBA 05/2011
1	tick subolesinIBA 03/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2010
1	Brucella melitensis Rev.1 vaccineIBA 05/2009
1	DefensinsIBA 12/2008
1	Perilipin-1IBA 02/2008
1	Complement System Proteins (Complement)IBA 08/2007
1	NucleotidesIBA 05/2007
1	Ribosomal DNA (rDNA)IBA 10/2006
1	Carrier Proteins (Binding Protein)IBA 03/2006
1	RNA (Ribonucleic Acid)IBA 03/2006
1	imidocarb dipropionateIBA 01/2006
1	ImidocarbIBA 01/2006
1	EnrofloxacinIBA 01/2006
1	Complementary DNA (cDNA)IBA 08/2005
1	Peptides (Polypeptides)IBA 08/2005
1	PolynucleotidesIBA 04/2005
1	16S Ribosomal RNAIBA 01/2005
1	Synthetic Vaccines (Recombinant Vaccines)IBA 08/2003
1	DNA ProbesIBA 03/2003
1	Immune Sera (Antisera)IBA 02/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2002
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2002

Therapy/Procedure

1	Therapeutics 04/2009
1	Drug Therapy (Chemotherapy) 04/2009
1	Enteral Nutrition (Feeding, Tube) 09/2005
1	Nutritional Support (Artificial Feeding) 08/2005